Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Bio-Rad Laboratories Inc News & Analysis
stocks
10 cheap wide-moat US stocks for 2025
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,375.90 | 19.70 | 0.21% |
CAC 40 | 8,188.59 | 111.59 | 1.38% |
DAX 40 | 24,272.19 | 90.82 | 0.38% |
Dow JONES (US) | 46,165.12 | 88.19 | -0.19% |
FTSE 100 | 9,436.09 | 11.34 | 0.12% |
HKSE | 25,888.51 | 22.09 | -0.09% |
NASDAQ | 22,661.52 | 8.56 | -0.04% |
Nikkei 225 | 48,277.74 | 605.07 | 1.27% |
NZX 50 Index | 13,389.10 | 81.70 | 0.61% |
S&P 500 | 6,658.29 | 12.77 | -0.19% |
S&P/ASX 200 | 9,068.40 | 18.20 | 0.20% |
SSE Composite Index | 3,916.23 | 4.02 | 0.10% |